Furthermore, it is possible that the administered dose of CHR-6494 (50 mg/kg) was not sufficient to inhibit HASPIN function, especially considering that the IC50 values of CHR-6494 are higher in breast cancer cell lines than in other cancer cell lines, such as HCT-116 and HeLa cells [22]. The gene discussed is HASPIN; the disease is breast carcinoma.